P688: ASC2ESCALATE: A US PHASE 2, OPEN-LABEL, SINGLE-ARM, DOSE-ESCALATION STUDY OF ASCIMINIB MONOTHERAPY IN 2ND-LINE (2L) TREATMENT OF PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP)
oleh: Ehab Atallah, Michael Mauro, Koji Sasaki, Moshe Yair Levy, Paul Koller, Islam Sadek, Daisy Yang, Julie Ruckel-Kumar, Mahmudul Khan, Jorge Cortes
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2023-08-01 |
Deskripsi
No description available for this item.